Gestational diabetes mellitus

Journal of Clinical Investigation

Volumn 115, Issue 3, 2005, Pages 485-491

  Buchanan, Thomas A ^a,b   Xiang, Anny H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GNH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

AUTOIMMUNE DISEASE; GENETIC SCREENING; GLUCOSE INTOLERANCE; HIGH RISK PREGNANCY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MASS SCREENING; PREGNANCY; RISK FACTORS;

EID: 14644409707     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200524531     Document Type: Review

References (72)

1. Duncan, M. 1882. On puerperal diabetes. Trans. Obstet. Soc. Lond. 24:256-285.
2. Miller, H.C. 1946. The effect of diabetic and prediabetic pregnancies on the fetus and newborn infant. J. Pediatr. 26:455-461.
3. Carrington, E.R., Shuman, C.R., and Reardon, H.S. 1957. Evaluation of the prediabetic state during pregnancy. Obstet. Gynecol. 9:664-669.
4. O'Sullivan, J.B., and Mahan, C.M. 1964. Criteria for the oral glucose tolerance test in ptegnancy. Diabetes. 13:278-285.
5. American Diabetes Association. 2003. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 26(Suppl. 1):S5-S20.
6. Naylor, C.D., Sermer, M., Chen, E., and Sykora, K. 1996. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? JAMA 275:1165-1170.
7. Magee, M.S., Walden, C.E., Benedetti, T.J., and Knopp, R.H. 1993. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA. 269:609-615.
8. Schmidt, M.I., et al. 2001. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care. 24:1151-1155.
9. Pettitt, D.J., and Knowler, W.C. 1998. Long-term effects of the intrauterine environment, birth weight, and breast-feeding on Pima Indians. Diabetes Care. 21(Suppl. 2):B138-B141.
10. Silverman, B.L., Rizzo, T.A., Cho, N.H., and Metzger, B.E. 1998. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes Care. 21(Suppl. 2):B142-B149.
11. Vohr, B.R., McGarvey, S.T., and Tucker, R. 1999. Effects of maternal gestational diabetes on off-spring adiposity at 4-7 years of age. Diabetes Care. 22:1284-1291.
12. American Diabetes Association. 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care. 27(Suppl. 1):S5-S10.
13. King, H. 1998. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing ige. Diabetes Care. 21(Suppl. 2):B9-B13.
14. Ben-Haroush, A., Yogev, Y., and Hod, M. 2004. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21:103-113.
15. Weijers, R.N., Bekedam, D.J., and Smulders, Y.M. 2002. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabetes Care. 23:72-77.
16. Gunton, J.E., Hitchman, R., and McElduff, A. 2001. Effects of ethnicity on glucose tolerance, insulin resistance and beta cell function in 223 women with an abnormal glucose challenge test during pregnancy. Aust. N. Z. J. Obstet. Gynecol. 41:182-186.
17. Xiang, A.M., et al. 1999. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes. 48:848-854.
18. Catalano, P.M., Huston, L., Amini, S.B., and Kalhan, S.C. 1999. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am. J. Obstet. Gynecol. 180:903-916.
19. Catalano, P.M., Tyzbir, E.D., Roman, N.M., Amini, S.B., and Sims, E.A. 1991. Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am. J. Obstet. Gynecol. 165:1667-1672.
20. Yen, S.C.C., Tsai, C.C., and Vela, P. 1971. Gestational diabetogenesis: quantitative analysis of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes. Am. J. Obstet. Gynecol. 111:792-800.
21. Buchanan, T.A., Metzger, B.E., Freinkel, N., and Bergman, R.N. 1990. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am. J. Obstet. Gynecol. 162:1008-1014.
22. Homko, C., Sivan, E., Chen, X., Reece, E.A., and Boden, G. 2001. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 86:568-573.
23. Kautzky-Willer, A., et al. 1997. Pronounced insulin resistance and inadequate betacell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 20:1717-1723.
24. Catalano, P.M., et al. 1993. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am. J. Physiol. 264:E60-E67.
25. Ryan, E.A., et al. 1995. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 44:506-512.
26. Osei, K., Gaillard, T.R., and Schuster, D.P. 1998. History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African-American women with a parental history of type 2 diabetes. Diabetes Care. 21:1250-1257.
27. Buchanan, T.A. 2001. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J. Clin. Endocrinol. Metab. 86:989-993.
28. Petersen, J.S., et al. 1996. GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy. Diabetologia. 39:1329-1333.
29. Weng, J., et al. 2002. Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care. 25:68-71.
30. Mauricio, D., et al. 1992. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy. Diabetes Nutr. Metab. 5:237-241.
31. Catalano, P.M., Tyzbir, E.D., and Sims, E.A.H. 1990. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care. 13:478-482.
32. Fajans, S.S., Bell, G.I., and Polonsky, K.S. 2001. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345:971-980.
33. Kousta, E., et al. 2001. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18:683-684.
34. Ellard, S., et al. 2000. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 43:250-253.
35. Saker, P.J., et al. 1996. High prevalence ofa missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia. 39:1325-1328.
36. Chen, Y., Liao, W.X., Roy, A.C., Loganath, A., and Ng, S.C. 2000. Mitochondrial gene mutations in gestational diabetes mellitus. Diabetes Res. Clin. Pract. 48:29-35.
37. Ward, W.K., et al. 1985. Insulin resistance and impaired insulin secretion in subjects with a history of gestational diabetes mellitus. Diabetes. 34:861-869.
38. Ward, W.K., Johnston, C.L.W., Beard, J.C., Benedetti, T.J., and Porte, D., Jr. 1985. Abnormalities of islet B cell function, insulin action and fat distribution in women with a history of gestational diabetes: relation to obesity. J. Clin. Endocrinol. Metab. 61:1039-1045.
39. Catalano, P.M., et al. 1986. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am. J. Obstet. Gynecol. 155:1255-1263.
40. Damm, P., Vestergaard, H., Kuhl, C., and Pedersen, O. 1996. Impaired insulin-stimulated nonoxidative glucose metabolism in glucose-tolerant women with previous gestational diabetes. Am. J. Obstet. Gynecol 174:722-729.
41. Kautzky-Willer, A., et al. 2001. Increased plasma leptin in gestational diabetes. Diabetologia. 44:164-172.
42. Winkler, G., et al. 2002. Tumor necrosis factor system and insulin resistance in gestational diabetes. Diabetes Res. Clin. Pract. 56:93-99.
43. Retnakaran, R., et al. 2003. C-reactive protein and gestational diabetes: the central role of maternal obesity. J. Clin. Endocrinol. Metab. 88:3507-3512.
44. Retnakaran, R., et al. 2004. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care. 27:799-800.
45. Williams, M.A., et al. 2004. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 89:2306-2311.
46. Tiikkainen, M., et al. 2002. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes. Res. 10:859-867.
47. Kautzky-Willer, A., et al. 2003, Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes. 52:244-251.
48. Damm, P., et al. 1993. Insulin receptor binding and tyrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetes. Obstet. Gynecol. 82:251-259.
49. Catalano, P.M., et al. 2002. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am. J. Physiol. 282:E522-E533.
50. Shao, J., Yamashita, H., Qiao, L., Draznin, B., and Friedman, J.E. 2002. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes. 51:19-29.
51. Shao, J., et al. 2000. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 over expression in skeletal muscle from obese women with gestational diabetes (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. Diabetes. 49:603-610.
52. Friedman, J.E., et al. 1999. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestarional diabetes. Diabetes. 48:1807-1814.
53. Garvey, W.T., et al. 1993. Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Diabetes. 42:1773-1785.
54. Zaidi, F.K., et al. 1997. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women. Diabet. Med. 14:228-234.
55. Leipold, H., et al. 2004. Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet. Gynecol. 103:1235-1240.
56. Rissanen, J., et al. 2000. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care. 23:70-73.
57. Kim, C., Newton, K.M., and Knopp, R.H. 2002. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care. 25:1862-1868.
58. Kjos, S.L., et al. 1990. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months postpartum. Am. J. Obstet. Gynecol. 163:93-98.
59. Peters, R.K., Kjos, S.L., Xiang, A., and Buchanan, T.A. 1996. Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet. 347:227-230.
60. Buchanan, T.A., et al. 2003. Changes in insulin secretion and sensitivity during the development of type 2 diabetes after gestational diabetes in Hispanic women. Diabetes. 52(Suppl. 1):A34.
61. Buchanan, T.A. et al. 2000. Response of pancreatic B-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes. 49:782-788.
62. Buchanan, T.A., et al. 2002. Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 51:2769-2803.
63. Langer, O., Conway, D.L., Berkus, M.D., Xenakis, E.M., and Gonzales, O. 2000. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343:1134-1138.
64. Hellmuth, E., Damm, P., and Molsted-Pedersen, L. 2000. Oral hypoglycaemic agents in 118 diabetic pregnancies. Acta. Obstet. Gynecol. Scand. 79:958-962.
65. Glueck, C.J., Goldenberg, N., Streicher, P., and Wang, P. 2003. Metformin and gestational diabetes. Curr. Diab. Rep. 3:303-312.
66. Kjos, S.L., et al. 2001. A randomized controlled trial utilizing glycemic plus fecal ultrasound parameters vs glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 24:1904-1910.
67. Buchanan, T.A., et al. 1994. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 17:275-283.
68. Kjos, S.L., Peters, R.K., Xiang, A., Schaefer, U., and Buchanan, T.A. 1998. Hormonal choices after gestational diabetes: subsequent pregnancy, contraception and hormone replacement. Diabetes Care. 21(Suppl. 2):B50-B57.
69. Towner, D., et al. 1995. Congenital malformations in pregnancies complicated by non-insulin-dependent diabetes mellitus: increased risk from poor maternal metabolic control but not from exposure to sulfonylurea drugs. Diabetes Care. 18:1446-1451.
70. Diabetes Prevention Program Research Group. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:393-403.
71. Xiang, A.M., et al. 2004. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and β-cell function. J. Clin. Endocrinol. Metab. 89:2846-2851.
72. Kjos, S.L., and Buchanan, T.A. 1999. Gestational diabetes mellitus. N. Engl. J. Med. 341:1749-1756.